Loading insider details...
Latest Form 4 (Jun 5, 2026): Grant/Award of 17,786 STOK shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 5, 2026 | Stoke Therapeutics, Inc. (STOK) | Grant/Award | 17,786 | n/a |
| May 29, 2026 | EXELIXIS, INC. (EXEL) | Grant/Award | 8,367 | n/a |
| Feb 20, 2026 | EXELIXIS, INC. (EXEL) | Exercise/Conversion | 42,422 | $771.7K |
| Jun 5, 2025 | Stoke Therapeutics, Inc. (STOK) | Grant/Award | 29,747 | n/a |
| May 30, 2025 | EXELIXIS, INC. (EXEL) | Grant/Award | 9,812 | n/a |
| Mar 1, 2025 | EXELIXIS, INC. (EXEL) | Exercise/Conversion | 31,167 | $638.9K |
| Aug 16, 2024 | EXELIXIS, INC. (EXEL) | Other (see footnotes) | 4,682 | n/a |
| Jun 7, 2024 | Stoke Therapeutics, Inc. (STOK) | Grant/Award | 7,639 | n/a |
| Jun 5, 2024 | EXELIXIS, INC. (EXEL) | Grant/Award | 10,015 | n/a |
| May 23, 2024 | EXELIXIS, INC. (EXEL) | Sale | 27,280 | $576.2K |